Fundraising FoxAMR Bio - company
1 known investors
Find your way into AMR Bio - company
Sign up to see every warm intro you have to AMR Bio - company
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AMR Bio - company team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AMR Bio develops XF-73, a first-in-class topical antimicrobial candidate in Phase 3 trials designed to prevent post-surgical infections, with the lead program targeting pre-operative decolonization in surgical settings. The company also advances dermal formulations for severe wound and skin infections.
Investors · 1
Frequently asked questions
- What does AMR Bio - company do?
- AMR Bio develops XF-73, a first-in-class topical antimicrobial candidate in Phase 3 trials designed to prevent post-surgical infections, with the lead program targeting pre-operative decolonization in surgical settings. The company also advances dermal formulations for severe wound and skin infections.
- Who are AMR Bio - company's investors?
- AMR Bio - company's investors include EMV Capital.